Cleared Abbreviated

K103709 - CERACELL DENTAL

K103709 is an FDA 510(k) clearance for CERACELL DENTAL, manufactured by Curasan AG. The device is a Class 2 Dental device with product code LYC cleared through the Abbreviated 510(k) pathway after a 80-day FDA review.

K103709 · Curasan AG · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2011
Decision
80d
Days
Class 2
Risk

K103709 is an FDA 510(k) clearance for the CERACELL DENTAL. Classified as Bone Grafting Material, Synthetic (product code LYC), Class II - Special Controls.

Submitted by Curasan AG (Rome, IT). The FDA issued a Cleared decision on March 10, 2011 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Curasan AG devices

FDA 510(k) Submission Details - K103709

510(k) Number K103709 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2010
Decision Date March 10, 2011
Days to Decision 80 days
Submission Type Abbreviated
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 127d · This submission: 80d
Pathway characteristics
Standards-based clearance path.

LYC Device Classification - Class 2, Special Controls

Product Code LYC Bone Grafting Material, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - LYC Bone Grafting Material, Synthetic

All 150
Devices cleared under the same product code (LYC) and FDA review panel - the closest regulatory comparables to K103709.
FOUNDATION
K111087 · Olympus Terumo Biomaterials Corporation · Nov 2011
REPROBONE DENTAL GRAFTING MATERIAL
K103820 · Ceramisys, Ltd. · Nov 2011
ENDOBON XENOGRAFT GRANULES
K110449 · Biomet 3i · May 2011
CARRIGEN
K100883 · Etex Corp. · Dec 2010
OSTEON, OSTEON SINUS, OSTEON LIFTING
K102015 · Genoss Co., Ltd. · Nov 2010
VITOMATRIX
K091618 · Orthovita, Inc. · Sep 2010